Amplia Therapeutics Limited(ATX) News

Date	Title
Jun 16	PATHOLOGICAL COMPLETE RESPONSE RECORDED IN PATIENT FROM ACCENT CANCER TRIAL
Sep 19	FDA FAST TRACK DESIGNATION FOR NARMAFOTINIB IN ADVANCED PANCREATIC CANCER
Feb 14	Amplia Therapeutics moves to next phase of pancreatic cancer treatment trial